- Home
- ELOG vs AEON Comparison
ELOG vs AEON Comparison
Compare ELOG & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELOG | AEON |
|---|---|---|
| Founded | 2006 | N/A |
| Country | China | United States |
| Employees | 138 | N/A |
| Industry | Integrated Freight & Logistics | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0M | 9.6M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ELOG | AEON |
|---|---|---|
| Price | $0.70 | $0.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.20 |
| AVG Volume (30 Days) | 2.8K | ★ 3.4M |
| Earning Date | 07-17-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.84 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.70 | $0.18 |
| 52 Week High | $3.07 | $1.45 |
Technical Indicators
Market Signals| Indicator | ELOG | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 39.71 | 51.41 |
| Support Level | N/A | $0.26 |
| Resistance Level | $0.98 | $0.34 |
| Average True Range (ATR) | 0.07 | 0.04 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 0.00 | 77.36 |
Price Performance
Historical ComparisonAbout ELOG Eastern International Ltd. Ordinary Shares
Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.